AstraZeneca Enters Another Major Market With This Indication
Late last month, Japan’s Ministry of Health, Labour, and Welfare (MHLW) approved AstraZeneca’s (NASDAQ:AZN) diabetes and heart failure drug, Forxiga (known as Farxiga in the United States), to treat patients with chronic kidney disease, or CKD. This made…
